Skip to content
Friday, May 23, 2025
  • Newsletter
  • Advisory Disclaimer
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us

"It does not matter how slowly you go as long as you do not stop." - Confucius

QualisBioMed

Medical Products Regulation in India

"Life can only be understood backwards; but it must be lived forwards." - Soren Kierkegaard

  • Home
  • Acts & Rules
  • Blog
  • Drugs
    • New Drugs
    • SND
    • FDC
    • Written Confirmation
    • WHO/COPP
    • Approved Drugs
  • Medical Products
    • Medical Devices
    • IVD
  • Cosmetics
  • Other Links
    • Regulatory Authorities
      • Regulatory Authorities
      • National Regulatory Authority (CDSCO Offices)
      • State FDA Contact Details
    • All Notifications
    • Gazette Notifications
    • Public Notices
    • Guidelines
    • NSQ Alerts
    • Serious Adverse Events (SAE)
    • Committees
      • DCC
      • DTAB
  • Community
  • Public Notices
  • Blog
  • Medical Devices

Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licenced medical device.

  • QualisBioMed
  • April 14, 2025
  • 0

In order to promote ease of doing business and to simplify the regulatory procedure, CDSCO vide its notice File No.: MED/52/2024-eoffice dated 09.04.2025 amended the […]

  • Blog
  • New Drugs

“New Drugs” in India

  • QualisBioMed
  • March 29, 2025
  • 0

In India, New Drugs are defined under New Drugs and Clinical Trials Rules, 2019 made under Drugs & Cosmetics Act, 1940. Definition: New Drugs (i) […]

  • Blog
  • Public Notices

Submission of online application for extension of time to comply with revised Sch M on ONDLS portal – www.statedrugs.gov.in

  • QualisBioMed
  • March 24, 2025
  • 0

Department of Health and Family Welfare has published a notification vide G.S.R. 127(E) dated 11th February 2025 regarding seeking extension of the timeline for implementation […]

  • Regulatory Authorities
  • Blog

National Regulatory Authority (NRA): CDSCO

  • QualisBioMed
  • March 22, 2025
  • 0

The Central Drugs Standard Control Organization (CDSCO) is the Central Drug Authority for discharging functions assigned to the Central Government under the Drugs and Cosmetics […]

  • Gazette Notifications
  • Blog

Application for grant of extension of compliance with Revised GMP under Schedule-M of the Drugs Rules, 1945.

  • QualisBioMed
  • March 22, 2025
  • 0

Central Government has extended the timeline as: “Provided that the small and medium manufacturers with turnover of or less than two hundred and fifty crores […]

  • Blog
  • Gazette Notifications

Reconstitution of Drugs Technical Advisory Board (DTAB) {S.O. 1159(E) dated 12.03.2025}

  • QualisBioMed
  • March 18, 2025
  • 0

In exercise to the powers conferred by sub-sections (1) and (2) of section 5 of the Drugs and Cosmetics Act, 1940 (23 of 1940) hereinafter […]

New Online Export NOC System on SUGAM Portal
  • Public Notices
  • Blog

New Online Export NOC System on SUGAM Portal

  • QualisBioMed
  • March 18, 2025
  • 0

To further enhance the ease of doing business in India, CDSCO has made online application system for submitting online application for obtaining Export NOC on […]

Categories

  • Blog
  • Gazette Notifications
  • Medical Devices
  • New Drugs
  • Public Notices
  • Regulatory Authorities

Recent Posts

  • Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licenced medical device.
  • “New Drugs” in India
  • Submission of online application for extension of time to comply with revised Sch M on ONDLS portal – www.statedrugs.gov.in
  • National Regulatory Authority (NRA): CDSCO
  • Application for grant of extension of compliance with Revised GMP under Schedule-M of the Drugs Rules, 1945.

Recent Comments

No comments to show.

Archives

  • April 2025
  • March 2025
Copyright © 2025 QualisBioMed Theme: Express News By Adore Themes.